Form 8-K - Current report:
SEC Accession No. 0001213900-16-010247
Filing Date
2016-01-19
Accepted
2016-01-19 16:04:41
Documents
18
Period of Report
2016-01-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k011916_immudyne.htm 8-K 21935
2 IMMUDYNE, INC. CORPORATE PRESENTATION Q1 2016 f8k011916ex99i_immudyne.htm EX-99.1 13594
3 GRAPHIC slide1.jpg GRAPHIC 61923
4 GRAPHIC slide2.jpg GRAPHIC 134454
5 GRAPHIC slide3.jpg GRAPHIC 138139
6 GRAPHIC slide4.jpg GRAPHIC 147647
7 GRAPHIC slide5.jpg GRAPHIC 122712
8 GRAPHIC slide6.jpg GRAPHIC 149078
9 GRAPHIC slide7.jpg GRAPHIC 159219
10 GRAPHIC slide8.jpg GRAPHIC 136056
11 GRAPHIC slide9.jpg GRAPHIC 127830
12 GRAPHIC slide10.jpg GRAPHIC 160363
13 GRAPHIC slide11.jpg GRAPHIC 116171
14 GRAPHIC slide12.jpg GRAPHIC 145616
15 GRAPHIC slide13.jpg GRAPHIC 189031
16 GRAPHIC slide14.jpg GRAPHIC 130578
17 GRAPHIC slide15.jpg GRAPHIC 180199
18 GRAPHIC slide16.jpg GRAPHIC 68012
  Complete submission text file 0001213900-16-010247.txt   3022799
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-184487 | Film No.: 161348365
SIC: 2833 Medicinal Chemicals & Botanical Products